Enzyme substrate analog inhibitor

Complementary structures of biological materials, especially those of proteins, often result in specific recognitions and various types of biological affinity. These include many pairs of substances, such as enzyme-inhibitor, enzyme-substrate (analog), enzyme-coenzyme, hormone-receptor, and antigen-antibody, as summarized in Table 11.2. Thus, bioaffinity represents a useful approach to separating specific biological materials. 

XAS has played a vital role in defining the chemical nature of these molybdenum centers and how they respond to changes in the oxidation level of the protein and/or to the presence of substrates, substrate analogs, or inhibitors of enzymatic activity (9, 13, 15). The prefix oxo for this latter group of enzymes is appropriate. Thus, not only does each enzyme catalyze a conversion, the net result of which can be represented as oxygen atom transfer, but also XAS studies have confirmed the presence of at least one terminal oxo ligand (Mo=0) for molybdenum in each of the enzymes. 

Initial rate measurements, especially with alternative substrates and with a product or substrate analog as inhibitor, and measurements of the rate of isotope exchange at equilibrium, can give a great deal of information about mechanism, and in some cases allow estimates of individual velocity constants and dissociation constants. The results of such studies, which require little enzyme, are an essential basis for the proper interpretation, in relation to the overall catalytic reaction, of pre-steady-state studies and kinetic and thermodynamic studies of enzyme-coenzyme reactions in isolation. 

Probably all adenylyl cyclases are inhibited competitively by substrate analogs, which bind at the site and to the enzyme configuration with which cation-ATP binds (cf Fig. 4). One of the best competitive inhibitors is (3-L-2, 3 -dideoxy adenosine-5 -triphosphate ( 3-L-2, 3 -dd-5 -ATP Table 4) [4], which allowed the identification of the two metal sites within the catalytic active site (cf Fig. 4) [3]. This ligand has also been labeled with 32P in the (3-phosphate and is a useful ligand for reversible, binding displacement assays of adenylyl cyclases [4]. The two inhibitors, 2, 5 -dd-3 -ATP and 3-L-2, 3 -dd-5 -ATP, are comparably potent... 

Inhibitors are usually classified according to their effect upon Vmax and Kn. Competitive inhibitors, such as substrate analogs, compete with the substrate for the same binding site on the enzyme, but do not interfere with the decomposition of the enzyme-substrate complex. Therefore, the primary effect of a competitive inhibitor is to increase the apparent value of Km. The effect of a competitive inhibitor can be reduced by increasing the substrate concentration relative to the concentration of the inhibitor. 

Concept A new approach to the rational design of enzyme inhibitors has emerged in the last ten to fifteen years that incorporates a substrate (or transition state) analog "core" molecule with additional binding determinants spanning beyond the immediate... 

To investigate the cofactor requirement and the characteristics of the enzyme, the effects of additives were examined using phenylmalonic acid as the representative substrate. The addition of ATP or ADP to the enzyme reaction mixtures, with or without coenzyme A, did not enhance the rate of reaction. From these results, it is concluded that these co-factors are not necessary for this decarboxylase. It is well estabhshed that avidin is a potent inhibitor of the bio-tin-enzyme complex [11 -14]. In the present case, addition of avidin has no influence on the decarboxylase activity, indicating that the AMDase is not a biotin enzyme. Thus, the co-factor requirements of AMDase are entirely different from those of known analogous enzymes, such as acyl-CoA carboxylases [15], methyhnalonyl-CoA decarboxylases [11] and transcarboxylases [15,16]. 

Substrate analogs (2) have properties similar to those of one of the substrates of the target enzyme. They are bound by the enzyme, but cannot be converted further and therefore reversibly block some of the enzyme molecules present. A higher substrate concentration is therefore needed to achieve a halfmaximum rate the Michaelis constant increases (B). High concentrations of the substrate displace the inhibitor again. The maximum rate V ax is therefore not influenced by this type of inhibition. Because the substrate and the inhibitor compete with one another for the same binding site on the enzyme, this type of inhibition is referred to as competitive. Analogs of the transition state (3) usually also act competitively. 

Generally, DNMT inhibitors can be divided in two big dasses. One group consists of base analogs which are incorporated into DNA and act as suidde substrates for DNMT via a covalent adduct formation. The other group acts on the free enzyme in the same way as classic enzyme inhibitors do. 

---